InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,842.47
(
0.47%
)
US TECH 100
19,606.00
(
-0.14%
)
Dow Jones
43,077.70
(
0.79%
)
Brent Oil
74.26
(
0.05%
)
Bitcoin
67,381.41
(
-0.35%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Kag

Send PM Follow Ignore
Followers 1
Posts 788
Boards Moderated 0
Alias Born 02/01/2006

Kag

Re: Gold Seeker post# 22171

Thursday, 09/03/2009 10:37:37 AM

Thursday, September 03, 2009 10:37:37 AM

Post# of 30387
Gold Seeker, you posted: “The Abbott glass is totally empty.”

My comment: Given the statement "Abbott shall have no further due diligence obligations whatsoever to commercialize or perform any further Research and Development on any product" that is stated in the March 31, 2008 amendment to the Abbott license agreement, and also the fact that it is going on five years since Abbott obtained its RECAF license, it is my opinion that a wise investor would not price anything from Abbott into the value of BioCurex stock. kag
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up